吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮
|
P697075-1g
|
≥97% |
21038-67-5 |
1g
|
¥ 1102.9
|
期货,请咨询 |
阿拉丁 |
吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮
|
P697075-100mg
|
≥97% |
21038-67-5 |
100mg
|
¥ 196.9
|
期货,请咨询 |
阿拉丁 |
哌啶-1-磺酰胺
|
P697062-5g
|
≥95% |
4108-90-1 |
5g
|
¥ 19071.9
|
期货,请咨询 |
阿拉丁 |
哌啶-1-磺酰胺
|
P697062-250mg
|
≥95% |
4108-90-1 |
250mg
|
¥ 2484.9
|
期货,请咨询 |
阿拉丁 |
哌啶-1-磺酰胺
|
P697062-1g
|
≥95% |
4108-90-1 |
1g
|
¥ 3890.9
|
期货,请咨询 |
阿拉丁 |
苯基甲烷磺酰肼
|
P697008-250mg
|
≥97% |
36331-57-4 |
250mg
|
¥ 540.9
|
期货,请咨询 |
阿拉丁 |
脱镁叶绿酸盐 A
|
P696855-250mg
|
≥95% |
15664-29-6 |
250mg
|
¥ 10019.9
|
期货,请咨询 |
阿拉丁 |
1-甲基-2,2-二苯基乙烯
|
P696683-250mg
|
≥95%, TBC作为稳定剂 |
778-66-5 |
250mg
|
¥ 2762.9
|
期货,请咨询 |
阿拉丁 |
1-甲基-2,2-二苯基乙烯
|
P696683-1g
|
≥95%, TBC作为稳定剂 |
778-66-5 |
1g
|
¥ 8914.9
|
期货,请咨询 |
阿拉丁 |
1-甲基-2,2-二苯基乙烯
|
P696683-100mg
|
≥95%, TBC作为稳定剂 |
778-66-5 |
100mg
|
¥ 1665.9
|
期货,请咨询 |
阿拉丁 |
肼基甲酸异丙酯
|
P696635-5g
|
≥95% |
6271-30-3 |
5g
|
¥ 4758.9
|
期货,请咨询 |
阿拉丁 |
肼基甲酸异丙酯
|
P696635-1g
|
≥95% |
6271-30-3 |
1g
|
¥ 1290.9
|
期货,请咨询 |
阿拉丁 |
3-甲氧基-4-羟基苯甲酸丙酯
|
P696632-250mg
|
≥95% |
6273-95-6 |
250mg
|
¥ 982.9
|
期货,请咨询 |
阿拉丁 |
3-甲氧基-4-羟基苯甲酸丙酯
|
P696632-1g
|
≥95% |
6273-95-6 |
1g
|
¥ 3027.9
|
期货,请咨询 |
阿拉丁 |
苯基(3-氯苯基)氨基甲酯
|
P696601-250mg
|
≥95% |
50699-50-8 |
250mg
|
¥ 1365.9
|
期货,请咨询 |
阿拉丁 |
苯基(3-氯苯基)氨基甲酯
|
P696601-1g
|
≥95% |
50699-50-8 |
1g
|
¥ 2730.9
|
期货,请咨询 |
阿拉丁 |
苯基(3-氯苯基)氨基甲酯
|
P696601-100mg
|
≥95% |
50699-50-8 |
100mg
|
¥ 702.9
|
期货,请咨询 |
阿拉丁 |
庚酸丙酯
|
P696539-500g
|
≥98% |
7778-87-2 |
500g
|
¥ 3287.9
|
期货,请咨询 |
阿拉丁 |
庚酸丙酯
|
P696539-25g
|
≥98% |
7778-87-2 |
25g
|
¥ 295.9
|
期货,请咨询 |
阿拉丁 |
庚酸丙酯
|
P696539-100g
|
≥98% |
7778-87-2 |
100g
|
¥ 902.9
|
期货,请咨询 |
阿拉丁 |
唑啉草酯
|
P696340-25mg
|
analytical standard |
243973-20-8 |
25mg
|
¥ 2899.9
|
期货,请咨询 |
阿拉丁 |
异丙基磺酰基苯
|
P696292-1g
|
≥98% |
4238-09-9 |
1g
|
¥ 3123.9
|
期货,请咨询 |
阿拉丁 |
脯氨酰谷氨酸
|
P696263-50mg
|
≥97% |
67644-00-2 |
50mg
|
¥ 5720.9
|
期货,请咨询 |
阿拉丁 |
脯氨酰谷氨酸
|
P696263-100mg
|
≥97% |
67644-00-2 |
100mg
|
¥ 10816.9
|
期货,请咨询 |
阿拉丁 |